Leaflet VIVIFLOR vaginal tablets


Indicated for: vaginal atrophy; restoration of vaginal flora

Route of administration: vaginal

Substance: Lactobacillus acidophilus + estriol (probiotic + estrogen)

ATC: G01AX14 (Genito urinary system and sex hormones | Antiinfectives and antiseptics, excl. combinations with corticosteroids | Other antiinfectives and antiseptics)

The combination of Lactobacillus acidophilus and estriolum is used for the treatment of atrophic vaginitis and imbalances in vaginal flora, particularly in postmenopausal women. Lactobacillus acidophilus helps restore normal vaginal flora, while estriol, an estrogen hormone, aids in the regeneration of vaginal mucosa.

The medication is administered as vaginal suppositories, usually once daily, as directed by a doctor. The duration of treatment varies depending on the severity of symptoms.

Common side effects include local irritation, itching, or a burning sensation. In rare cases, allergic reactions or increased sensitivity to estriol may occur.

This combination is not recommended for pregnant or breastfeeding women. Patients should inform their doctor about any other medications being used to avoid drug interactions.

General data about VIVIFLOR

  • Substance: Lactobacillus acidophilus + estriol
  • Date of last drug list: 01-05-2026
  • Commercial code: W67378001
  • Pharmaceutical form: vaginal tablets
  • Quantity: 6
  • Product type: original
  • Price: 41.34 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: HAUPT PHARMA AMAREG GmbH - GERMANIA
  • Holder: BAUSCH HEALTH IRELAND LIMITED - IRLANDA
  • Number: 9432/2016/01
  • Shelf life: 3 years